| ID | 119126 |
| 著者 |
Okada, Masaki
Sakamoto Hospital
Iwatsuki, Noboru
Sakamoto Hospital
Sakamoto, Kazuki
Sakamoto Hospital
Ogawa, Tomoya
Sakamoto Hospital
|
| キーワード | Imeglimin (Twymeeg)
Type 2 Diabetes
Zinc Acetate Hydrate
Novelzin
Trials of IMeglimin for Efficacy and Safety
Neuropsychiatric Symptoms in Dementia
Alzheimer's-Plus with Low Zinc
|
| 資料タイプ |
学術雑誌論文
|
| 抄録 | Background: Recent diabetic focus includes imeglimin (Twymeeg).
Case Presentation: The case was an 83-year-old female with 19 years of type 2 diabetes (T2D) associated with recent treatment for dementia. Result: HbA1c decreased from 10.0% to 6.6% for 4 months by Twymeeg 2000 mg/day. For neuropsychiatric symptoms in dementia, memantine and tiapride were provided and controlled. Furthermore, zinc acetate hydrate (Novelzin) was continued for T2D and dementia. Discussion and Conclusion: Twymeeg administration was effective as the results of Trials of IMeglimin for Efficacy and Safety (TIMES) 2 and 3. Perspectives on the efficacy of zinc were discussed including Alzheimer's-Plus with low zinc (APLZ). |
| 掲載誌名 |
Asploro Journal of Biomedical and Clinical Case Reports
|
| ISSN | 25820370
|
| 出版者 | Asploro
|
| 巻 | 6
|
| 号 | 1
|
| 開始ページ | 17
|
| 終了ページ | 22
|
| 発行日 | 2023-02-04
|
| 権利情報 | This is an open-access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
|
| 出版社版DOI | |
| 出版社版URL | |
| フルテキストファイル | |
| 言語 |
eng
|
| 著者版フラグ |
出版社版
|
| 部局 |
医学系
|
